Skip to main content
Erschienen in: Head and Neck Pathology 3/2016

17.11.2015 | Case Report

Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation

verfasst von: Iyer Vishwas Neelakantan, Silvana Di Palma, C. E. T. Smith, A. McCoombe

Erschienen in: Head and Neck Pathology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Sebaceous carcinoma of parotid gland are extremely rare with only 29 cases reported so far. The development of parotid sebaceous carcinoma in association with mutation in the mismatch repair gene that causes Muir Torre Syndrome (MTS), a subset of Lynch Syndrome, is still unclear. This study describes such a case and reviews the literature to see if an association between parotid sebaceous carcinoma and multiple visceral malignancies seen in Lynch Syndrome has ever been described. MTS represents a small subset of the Hereditary Non Polyposis Colorectal Carcinoma family, thought to be a subtype of Lynch Syndrome, where patients are prone to develop multiple visceral cancers involving gastrointestinal and genitourinary tract along with sebaceous and non-sebaceous tumours of the skin. MTS is a rare hereditary, autosomal dominant cancer syndrome caused by Microsatellite Instability and defect in DNA mismatch repair protein. The germline mutation involves mostly hMSH2 and hMLH1 genes. In MTS the skin of the head and neck area with the periocular region in particular, is affected but sebaceous carcinomas of the parotid associated with visceral malignancies has not yet been reported in literature. Here we report an index case of sebaceous carcinoma of parotid gland in a patient with MTS.
Literatur
1.
Zurück zum Zitat Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthoma of the face. Br J Surg. 1967;54(3):191–5.CrossRefPubMed Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthoma of the face. Br J Surg. 1967;54(3):191–5.CrossRefPubMed
4.
Zurück zum Zitat Navi D, wadhera A, Fung MA, Fazel N. Muir Torre syndrome. Dermatol Online J. 2006;12(5):4.PubMed Navi D, wadhera A, Fung MA, Fazel N. Muir Torre syndrome. Dermatol Online J. 2006;12(5):4.PubMed
5.
Zurück zum Zitat Hare HH, Mahendraker N, Sarwate S, Tangella K. Muir Torre syndrome: rare but important disorder. Cutis. 2008;82(4):252–6.PubMed Hare HH, Mahendraker N, Sarwate S, Tangella K. Muir Torre syndrome: rare but important disorder. Cutis. 2008;82(4):252–6.PubMed
6.
Zurück zum Zitat Pettey AA, Walsh JS. Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005;75(3):149–55.PubMed Pettey AA, Walsh JS. Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005;75(3):149–55.PubMed
7.
Zurück zum Zitat Heather JH, Melissa V, Jean MH. Muir Torre syndrome: a case report. J Clin Aesthet Dermatol. 2009;2:8. Heather JH, Melissa V, Jean MH. Muir Torre syndrome: a case report. J Clin Aesthet Dermatol. 2009;2:8.
8.
Zurück zum Zitat Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 1996;56:4836–40.PubMed Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 1996;56:4836–40.PubMed
9.
Zurück zum Zitat Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000;6:1784–9.PubMed Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000;6:1784–9.PubMed
10.
Zurück zum Zitat Kruse R, Rutten A, Schweiger N, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol. 2003;120(5):858–64.CrossRefPubMed Kruse R, Rutten A, Schweiger N, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol. 2003;120(5):858–64.CrossRefPubMed
11.
Zurück zum Zitat Christopher DS, Heather H, Ilene C, Judith AW, Wendy LF, Albert C. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277–81.CrossRef Christopher DS, Heather H, Ilene C, Judith AW, Wendy LF, Albert C. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277–81.CrossRef
12.
Zurück zum Zitat Bapat B, Xia L, Madlensky L, et al. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996;59(3):736–9.PubMedPubMedCentral Bapat B, Xia L, Madlensky L, et al. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996;59(3):736–9.PubMedPubMedCentral
13.
Zurück zum Zitat Ponti G, Ponz de Leon M, Losi L, et al. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Br J Dermatol. 2005;152(6):1335–8.CrossRefPubMed Ponti G, Ponz de Leon M, Losi L, et al. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Br J Dermatol. 2005;152(6):1335–8.CrossRefPubMed
14.
Zurück zum Zitat Pagenstecher C, Mangold E, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004;41:567–72.CrossRefPubMedPubMedCentral Pagenstecher C, Mangold E, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004;41:567–72.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002;29(7):415–20.CrossRefPubMed Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002;29(7):415–20.CrossRefPubMed
16.
Zurück zum Zitat Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquerader, emerging concepts in diagnosis and treatment. Dermatol Therapy. 2008;21:459–66.CrossRef Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquerader, emerging concepts in diagnosis and treatment. Dermatol Therapy. 2008;21:459–66.CrossRef
18.
Zurück zum Zitat Akhtar S, Oza KK, Khan SA, Wright J. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999;41(5):681–6.CrossRefPubMed Akhtar S, Oza KK, Khan SA, Wright J. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999;41(5):681–6.CrossRefPubMed
19.
Zurück zum Zitat Harkness EF, Barrow E, Newton K, Green K, Clancy T, Lalloo F, Hill J, Evans GD. Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study. J Med Genet. 2015;52(8):553–6.CrossRefPubMed Harkness EF, Barrow E, Newton K, Green K, Clancy T, Lalloo F, Hill J, Evans GD. Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study. J Med Genet. 2015;52(8):553–6.CrossRefPubMed
20.
Zurück zum Zitat Akbari D, Naraghi Z, Emadi N, Ghaninejad H. Extraocular Sebaceous carcinoma arising from nevus sebaceous. Acta Med Iran. 2005;43(3):227–9. Akbari D, Naraghi Z, Emadi N, Ghaninejad H. Extraocular Sebaceous carcinoma arising from nevus sebaceous. Acta Med Iran. 2005;43(3):227–9.
21.
Zurück zum Zitat Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33(1):90–104.CrossRefPubMed Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33(1):90–104.CrossRefPubMed
22.
Zurück zum Zitat Cohen PR, Kohn SR, Davis DA, Kurzrock R. Muir-Torre syndrome. Dermatol Clin. 1995;13(1):79–89.PubMed Cohen PR, Kohn SR, Davis DA, Kurzrock R. Muir-Torre syndrome. Dermatol Clin. 1995;13(1):79–89.PubMed
23.
Zurück zum Zitat Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk associated neoplasms: insight into Muir Torre syndrome. Cancer. 2008;113(12):3372–81.CrossRefPubMedPubMedCentral Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk associated neoplasms: insight into Muir Torre syndrome. Cancer. 2008;113(12):3372–81.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Shalin SC, Lyle S, Calonje E, Lazar AJF. Sebaceous neoplasia and Muir Torre syndrome: important connection with clinical implication. Histopathology. 2010;56(1):133–47.CrossRefPubMedPubMedCentral Shalin SC, Lyle S, Calonje E, Lazar AJF. Sebaceous neoplasia and Muir Torre syndrome: important connection with clinical implication. Histopathology. 2010;56(1):133–47.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Gnepp DR, Brannon R. Sebaceous neoplasms of salivary gland origin. Report of 21 cases. Cancer. 1984;53:2155–70.CrossRefPubMed Gnepp DR, Brannon R. Sebaceous neoplasms of salivary gland origin. Report of 21 cases. Cancer. 1984;53:2155–70.CrossRefPubMed
27.
Zurück zum Zitat Mill SE, Carter D, Greenson JK, Reutor VE, Stoler MH. Sternberg’s diagnostic surgical pathology. 5th ed. Wolter Kluwer/Lippincot Williams and Wilkins; 2010. Mill SE, Carter D, Greenson JK, Reutor VE, Stoler MH. Sternberg’s diagnostic surgical pathology. 5th ed. Wolter Kluwer/Lippincot Williams and Wilkins; 2010.
28.
Zurück zum Zitat Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head neck tumours. 3rd ed. Geneva: WHO Press; 2005. Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head neck tumours. 3rd ed. Geneva: WHO Press; 2005.
29.
Zurück zum Zitat Barnes L. Surgical pathology of head and neck. 3rd ed. London: Taylor and Francis Inc; 2008.CrossRef Barnes L. Surgical pathology of head and neck. 3rd ed. London: Taylor and Francis Inc; 2008.CrossRef
30.
Zurück zum Zitat Di Palma S, Skalova A, Simpson R, Leivo IS, Fonseca I. Major and minor salivary glands. Pathology of the head and neck. Chapter 5. 2nd ed. Springer; 2015 (in press). Di Palma S, Skalova A, Simpson R, Leivo IS, Fonseca I. Major and minor salivary glands. Pathology of the head and neck. Chapter 5. 2nd ed. Springer; 2015 (in press).
31.
Zurück zum Zitat Madrigal FM, Micheau C. Histology of major salivary glands. Am J Surg Pathol. 1989;13(10):879–99.CrossRef Madrigal FM, Micheau C. Histology of major salivary glands. Am J Surg Pathol. 1989;13(10):879–99.CrossRef
32.
Zurück zum Zitat Neville BW, Damm DD, Allen CM, et al. Oral and maxillofacial pathology 2. Philadelphia: W. B Saunders; 2002. p. 6–7. Neville BW, Damm DD, Allen CM, et al. Oral and maxillofacial pathology 2. Philadelphia: W. B Saunders; 2002. p. 6–7.
33.
Zurück zum Zitat De Felice C, Parrini S, Chitano G, Gentile M, Dipaola L, Latini G. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut. 2005;54:1279–82.CrossRefPubMedPubMedCentral De Felice C, Parrini S, Chitano G, Gentile M, Dipaola L, Latini G. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut. 2005;54:1279–82.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Akhtar M, Gosalbez TG. Primary sebaceous carcinoma of Parotid Gland. Arch Pathol. 1973;96:161–3.PubMed Akhtar M, Gosalbez TG. Primary sebaceous carcinoma of Parotid Gland. Arch Pathol. 1973;96:161–3.PubMed
35.
Zurück zum Zitat Shulman J, Waisman J, Morledge D. Sebaceous carcinoma of parotid gland. Arch Otolaryngol. 1973;98:417–21.CrossRefPubMed Shulman J, Waisman J, Morledge D. Sebaceous carcinoma of parotid gland. Arch Otolaryngol. 1973;98:417–21.CrossRefPubMed
36.
Zurück zum Zitat Siriwardena BSMS, Tilakaratne WM, Rajapakshe RMSK. A case of sebaceous carcinoma of the parotid gland. J Oral Pathol Med; 32:121–123. Siriwardena BSMS, Tilakaratne WM, Rajapakshe RMSK. A case of sebaceous carcinoma of the parotid gland. J Oral Pathol Med; 32:121–123.
37.
Zurück zum Zitat Silver H, Goldstein MA. Sebaceous cell carcinoma of the parotid gland. Cancer. 1966;19:1773–9.CrossRefPubMed Silver H, Goldstein MA. Sebaceous cell carcinoma of the parotid gland. Cancer. 1966;19:1773–9.CrossRefPubMed
38.
Zurück zum Zitat MacFarlane JK, Viloria JB, Palmer JD. Sebaceous cell carcinoma of Parotid Gland. Am J Surg; 130:499–501. MacFarlane JK, Viloria JB, Palmer JD. Sebaceous cell carcinoma of Parotid Gland. Am J Surg; 130:499–501.
39.
Zurück zum Zitat Grieve TP, Saragas E, Mannell A. Sebaceous carcinoma of parotid gland in a black patient. S Afr Med J. 1986;69:141–2.PubMed Grieve TP, Saragas E, Mannell A. Sebaceous carcinoma of parotid gland in a black patient. S Afr Med J. 1986;69:141–2.PubMed
40.
Zurück zum Zitat Warman M, Mozes M, Halperin D. Sebaceous Adenocarcinoma of the Parotid Gland: a case report and review of literature. Internet J Otorhinolaryngol. 2008;9:1–2. Warman M, Mozes M, Halperin D. Sebaceous Adenocarcinoma of the Parotid Gland: a case report and review of literature. Internet J Otorhinolaryngol. 2008;9:1–2.
41.
Zurück zum Zitat Das K, Karmakar A. Sebaceous Carcinoma of parotid Gland. Gomal Jo Med Sci. 2014;12:122–3. Das K, Karmakar A. Sebaceous Carcinoma of parotid Gland. Gomal Jo Med Sci. 2014;12:122–3.
42.
Zurück zum Zitat Mighell AJ, Stassen LFA, Soames JV. Sebaceous carcinoma of parotid gland. Dentalmaxillofac. Radiol. 1996;25:51–4.CrossRef Mighell AJ, Stassen LFA, Soames JV. Sebaceous carcinoma of parotid gland. Dentalmaxillofac. Radiol. 1996;25:51–4.CrossRef
43.
44.
Zurück zum Zitat Alexander M, Seth Z, Vivian G. Sebaceous carcinoma of parotid gland. A case report and review of literature. ENT J. 2014;6:1–6. Alexander M, Seth Z, Vivian G. Sebaceous carcinoma of parotid gland. A case report and review of literature. ENT J. 2014;6:1–6.
45.
Zurück zum Zitat Takata T, Ogawa I, Nikai H. Sebaceous Carcinoma of parotid gland. An Immunohistochemical and ultrastructural study. Virchows Archiv A Pathol Anat. 1989;414:459–64.CrossRef Takata T, Ogawa I, Nikai H. Sebaceous Carcinoma of parotid gland. An Immunohistochemical and ultrastructural study. Virchows Archiv A Pathol Anat. 1989;414:459–64.CrossRef
46.
Zurück zum Zitat Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med. 1981;141(5):607–11.CrossRefPubMed Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med. 1981;141(5):607–11.CrossRefPubMed
48.
Zurück zum Zitat Mathiak M, Rutten A, Mangold E, Fisher HP, et al. Loss of DNA mismatch repair proteins in skin tumours from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002;26:338–43.CrossRefPubMed Mathiak M, Rutten A, Mangold E, Fisher HP, et al. Loss of DNA mismatch repair proteins in skin tumours from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002;26:338–43.CrossRefPubMed
49.
Zurück zum Zitat Standring S. Grays anatomy. 40th ed. London: Churchill Livingstone; 2009. Standring S. Grays anatomy. 40th ed. London: Churchill Livingstone; 2009.
50.
Zurück zum Zitat Tryggvason G, Bayon R, Pagedar NA. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck. 2012;34(12):1765–8.CrossRefPubMed Tryggvason G, Bayon R, Pagedar NA. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck. 2012;34(12):1765–8.CrossRefPubMed
Metadaten
Titel
Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation
verfasst von
Iyer Vishwas Neelakantan
Silvana Di Palma
C. E. T. Smith
A. McCoombe
Publikationsdatum
17.11.2015
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2016
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-015-0670-9

Weitere Artikel der Ausgabe 3/2016

Head and Neck Pathology 3/2016 Zur Ausgabe

Sine qua non Radiology-Pathology

Dedifferentiated Chondrosarcoma of the Larynx

Sine qua non Radiology-Pathology

Myositis Ossificans of the Temporalis Muscle

Neu im Fachgebiet Pathologie